- Author:
Chun-mei CHEN
1
;
Yong-tang JIN
;
He-yun XU
;
Chen-ye ZHANG
;
Hu ZHANG
;
Wei-min ZHANG
;
Cong TAN
;
Xiao-yu SUN
Author Information
- Publication Type:Journal Article
- MeSH: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Carcinogens; Case-Control Studies; Cytochrome P-450 CYP1A1; genetics; DNA Adducts; genetics; Female; Genotype; Glutathione Transferase; genetics; Humans; Lung Neoplasms; chemically induced; enzymology; genetics; Male; Middle Aged; Polymorphism, Genetic
- From: Chinese Journal of Medical Genetics 2012;29(1):23-27
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of CYP1A1 and GSTM1 genetic polymorphisms and BPDE-DNA adducts on lung tumorigenesis.
METHODSThe case control study has included 200 cases of lung cancer and 200 controls. DNA was extracted from blood samples of all subjects. The genotype of both CYP1A1 and GSTM1 were detected with PCR-based restriction fragment length polymorphisms (PCR-RELP). BPDE-DNA adducts were detected with competitive ELISA.
RESULTSCYP1A1 mutant genotype and GSTM1 null genotype with smoke has increased the risk of lung cancer, with OR being 2.406(1.321-4.382), 2.755(1.470-5.163), respectively. The level of BPDE-DNA adducts in patients was greater than control, and the adduct level in ever smokers was higher than never smokers, the difference was statistically significant (P= 0.0252). GSTM1 null genotype individuals with BPDE-DNA level higher than 5 adducts/10(8) nucleotide have increased risk of lung cancer (OR= 1.988, 95%CI: 1.011-3.912). Compared with never smokers with CYP1A1 wild genotype, smokers with CYP1A1 mutation genotype had an increased risk of forming a higher level of DNA adducts (P= 0.0459). Smokers with GSTM1 null genotype formed more DNA adducts compared with never smokers with GSTM1 functional genotype (OR = 2.432, 95% CI: 1.072-4.517).
CONCLUSIONGSTM1 null genotype with higher level DNA adducts may increase the risk of lung cancer. DNA adducts form easier in smokers with CYP1A1 mutation genotype and GSTM1 null genotype, which in turn may influence lung tumorigenesis.